Bevacizumab
200709051M
Phase 3 small_molecule completed
Quick answer
Bevacizumab for Proliferative Diabetic Retinopathy is a Phase 3 program (small_molecule) at Hospital Authority, Hong Kong with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Hospital Authority, Hong Kong
- Indication
- Proliferative Diabetic Retinopathy
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed